Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island

Despite its proven efficacy, buprenorphine remains dramatically underutilized for management of opioid use disorder largely due to onerous barriers to treatment initiation. During the COVID-19 pandemic, many substance use disorder treatment facilities have reduced their hours and services, exacerbat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Subst Abuse Treat
Autores principales: Clark, Seth A., Davis, Corey, Wightman, Rachel S., Wunsch, Caroline, Keeler, Lee Ann Jordison, Reddy, Neha, Samuels, Elizabeth A.
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7817486/
https://ncbi.nlm.nih.gov/pubmed/33771282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2021.108283
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares